Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolerability and Safety of Two Formulations of Glatiramer Acetate
NCT00947752Phase 3Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Jul 2009
- Primary completion
- Sep 2009
- Modality
- Peptides, Recombinant Proteins and Enzymes
01
Overview
A Phase 3 trial of glatiramer acetate in multiple sclerosis (MS), sponsored by Teva Pharmaceutical Industries Ltd.. Started Jul 2009; status: completed.
02
Drugs
glatiramer acetate
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00947752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00947752.